What is NDC 59651-798?

59651-798 is the product NDC for Furosemide, Furosemide 80 mg/1 tablet, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Furosemide?

211 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Furosemide NDC 59651-798 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-798Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0798Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-798-01	59651079801	100 TABLET in 1 BOTTLE (59651-798-01)Marketed from Jul 17, 2025
59651-798-05	59651079805	500 TABLET in 1 BOTTLE (59651-798-05)Marketed from Jul 17, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Furosemide
Generic name (nonproprietary): furosemide
Active ingredients: Furosemide — 80 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 59651
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218831
Marketing start: Jul 17, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 59651-798_a504ee4b-3995-45f2-898c-91116dd81d19SPL ID a504ee4b-3995-45f2-898c-91116dd81d19SPL set ID a504ee4b-3995-45f2-898c-91116dd81d19RxCUI 197732, 310429, 313988UNII 7LXU5N7ZO5
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651079801 followed by a unit qualifier and the quantity

Package 59651-0798-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 19, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Edema Furosemide tablets are indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide tablets are particularly useful when an agent with greater diuretic potential is desired. Hypertension Oral furosemide tablets may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. Hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with furosemide tablets alone.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59651-798

What is NDC 59651-798?: 59651-798 is the product NDC for Furosemide, Furosemide 80 mg/1 tablet, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Furosemide.
What is the active ingredient?: Furosemide.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Furosemide?: 211 other product NDCs are listed under this name. See all Furosemide NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Furosemide NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Furosemide	Furosemide 10 mg/mL	InjectionIntramuscular, Intravenous	Civica, Inc.	72572-275	72572-0275-10
Furosemide	Furosemide 20 mg/1	TabletOral	REMEDYREPACK INC.	70518-4679	70518-4679-00
Furosemide	Furosemide 20 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-033	87441-0033-01
Furosemide	Furosemide 20 mg/1	TabletOral	Coupler LLC	67046-0768	67046-0768-03
Furosemide	Furosemide 40 mg/1	TabletOral	REMEDYREPACK INC.	70518-4609	70518-4609-00
Furosemide	Furosemide 40 mg/1	TabletOral	Coupler LLC	67046-1663	67046-1663-03
Furosemide	Furosemide 20 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-832	10135-0832-0110135-0832-1010135-0832-90
Furosemide	Furosemide 40 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-833	10135-0833-0110135-0833-1010135-0833-90
Furosemide	Furosemide 80 mg/1	TabletOral	Marlex Pharmaceuticals, Inc.	10135-834	10135-0834-0110135-0834-0510135-0834-90
Furosemide	Furosemide 20 mg/1	TabletOral	Granulation Technology, Inc.	63561-0164	63561-0164-0163561-0164-0263561-0164-09

All 212 Furosemide NDCs

Other NDCs under ANDA 218831

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218831
Product	Strength	Form · route	Labeler	Product NDC
Furosemide	Furosemide 20 mg/1	TabletOral	Aurobindo Pharma Limited	59651-796
Furosemide	Furosemide 40 mg/1	TabletOral	Aurobindo Pharma Limited	59651-797